IDEXX LABORATORIES INC /DE Accrued Income Taxes, Current
IDEXX LABORATORIES INC /DE (IDXX) had Accrued Income Taxes, Current of $76.10 million as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedIncomeTaxesCurrent · last filed 2026-08-04
- 2026-06-30: Accrued Income Taxes, Current $76.10M.
- 2026-03-31: Accrued Income Taxes, Current $80.03M.
- 2025-12-31: Accrued Income Taxes, Current $88.67M.
- 2025-09-30: Accrued Income Taxes, Current $89.20M.
| Period end | Accrued Income Taxes, Current |
|---|---|
| 2026-06-30 | $76.10M 10-Q · filed 2026-08-04 |
| 2026-03-31 | $80.03M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $88.67M 10-Q · filed 2026-08-04 |
| 2025-09-30 | $89.20M 10-Q · filed 2025-11-03 |
| 2025-06-30 | $75.21M 10-Q · filed 2025-08-04 |
| 2025-03-31 | $101.93M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $62.25M 10-K · filed 2026-02-20 |
| 2024-09-30 | $80.07M 10-Q · filed 2024-10-31 |
| 2024-06-30 | $146.37M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $134.19M 10-Q · filed 2024-05-01 |
| 2023-12-31 | $86.55M 10-K · filed 2025-02-21 |
| 2023-09-30 | $50.26M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $56.41M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $72.83M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $48.55M 10-K · filed 2024-02-22 |
| 2022-09-30 | $34.71M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $22.10M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $84.15M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $42.60M 10-K · filed 2023-02-16 |
| 2021-09-30 | $43.54M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $39.43M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $59.48M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $42.68M 10-K · filed 2022-02-16 |
| 2020-09-30 | $40.01M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $55.69M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $33.35M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $31.11M 10-K · filed 2021-02-12 |
| 2019-09-30 | $26.37M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $25.62M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $36.33M 10-Q · filed 2019-05-01 |
| 2018-12-31 | $26.61M 10-K · filed 2020-02-14 |
| 2018-09-30 | $28.08M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $25.11M 10-Q · filed 2018-08-01 |
| 2018-03-31 | $26.45M 10-Q · filed 2018-05-04 |
| 2017-12-31 | $29.39M 10-K · filed 2019-02-15 |
| 2016-12-31 | $23.97M 10-K · filed 2018-02-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |